Skip to content
The BCI Briefing

Company profilePeripheral / neuromotor interface

BrainCo强脑科技

Non-invasive neural interfaces sold as products: bionic limbs and EEG wearables.

Location
Hangzhou, China
Founded
2015
Class
Peripheral / neuromotor interfaceIts prosthetic hands are controlled by muscle signals. It also sells EEG headbands for attention training and sleep, which are consumer products and not implanted BCIs.Not counted among core BCI companies.
Also known as
Qiangnao Keji
Funding stage
Late stage; Hong Kong listing application reported
Sources last checked
5 Oct 2026

What they are building

Hangzhou company making muscle-signal-controlled bionic hands and legs and EEG-based wearables. It does not implant devices.

Signal
sEMG: Motor-unit action potentialsEEG: Summed field potentials, blurred and attenuated by skull and scalp
Invasiveness
Non-invasive
Recording / stimulation
Recording
Main use cases
Augment, Move

Where they are clinically

Non-medical product

Sold as a consumer product. It has not been evaluated or authorised as a medical device.

Sells assistive and consumer products. Regulatory status differs by product and country, and none is an implanted BCI.

Access today

Available

Authorised and obtainable for a defined group of patients or users.

Shown in people
Products on sale: prosthetic hands controlled by muscle signals, and EEG headbands. It has no implanted work.
Still an aim
A public listing. A confidential Hong Kong filing was reported in January 2026.
What stands in the way
Signal: muscle and scalp recordings carry far less information than an implant, which bounds what the products can do.

On record here: 0 peer-reviewed papers

Why this company matters

BrainCo is the largest capital story in neural interfaces outside the United States, and it is a non-invasive one. Its bionic hands read muscle, not brain, and its EEG products make modest claims. That is the point: it is the clearest test of whether neural-interface technology can be a consumer and assistive-device business at scale before any implant is.

Key milestones

  1. 12 Jan 2026

    Reported to have filed confidentially for a Hong Kong listing.

    财联社 (Cailian Press), carried by 21财经

  2. 8 Jan 2026

    Financing of CNY 2 billion (USD 286.3 million) reported, co-led by IDG Capital and Walden International.

    Yicai Global

Funding history

  • 8 Jan 2026$286.3MFinancing round · led by IDG Capital, Walden InternationalAnnounced as CNY 2 billion; the dollar figure is the one the report gives.The round was not given a series name. BrainCo makes non-invasive products, not implants.

Investors namedIDG Capital · Walden International · Lens Technology · OmniVision

Rounds in the Briefing’s sample only; not a complete funding history.

Leadership

  • Han Bicheng (韩璧丞)

    Founder

As publicly stated by the organisation. Not a complete list.

IP and patents

Filings touch 4 of the 11 layers, led by interface and electrodes (8 of 18 families) and application (5).

18
patent families identified and counted as BCI
2017
earliest first filing among them
10
first filed since 2021; the latest years are incomplete
9 of 18
include a granted member, of those whose family record was read

Across the stack: families by layer

Themes, by number of families: electrodes and arrays (5), assistive and control applications (5), peripheral interfaces (4), signal processing (4), stimulation (4), signal acquisition (2). A family can carry several.

Published in: China (18), United States (2), counted over the 18 families whose full record was read.

12 more families counted, and 139 kept as adjacent neural technology

The 60 most recent are listed.

Families found for BrainCo in the EPO’s worldwide database, grouped so that one invention counts once. A filing shows what a company sought to protect. It does not show that the technology was built, is in a product, or works in people, and themes are read from titles, abstracts and classes, not from the claims. How to read this

Competitive context

Sources

  1. 01

    China's BrainCo Raises USD286 Million, Most for a Brain Chip Developer Outside the US (opens in a new tab)

    Independent reportingYicai Global8 Jan 2026Checked against source 4 Oct 2026

    Gives the amount in both currencies, the co-leads and two further investors. The round is not named.

  2. 02

    'Hangzhou Six' Tech Startup BrainCo Is Said to File for Hong Kong IPO (opens in a new tab)

    Independent reportingBloomberg12 Jan 2026Source identified, not opened

    Identified through search; not opened. Reports a confidential filing from unnamed sources. The filing is also reported by Cailian Press, listed beside it.

  3. 03

    Who will be the first listed brain-computer interface company? (opens in a new tab)

    Independent reporting财联社 (Cailian Press), carried by 21财经14 Jun 2026Checked against source 5 Oct 2026

    Chinese financial press, read in machine translation. States that the Shanghai Stock Exchange accepted the STAR Market application of 博睿康技术(上海)股份有限公司 (Neuracle) on 11 June 2026, that the company was founded in November 2011, that BrainCo filed confidentially in Hong Kong in January 2026, and that StairMed completed a strategic financing of RMB 500 million in March 2026. Amounts were not re-checked against the prospectus.